Retrospective analysis of clinical outcomes of patients with COVID-19 depending on receiving antihypertensive, lipid-lowering and antihypertensive therapy

Retrospective analysis of clinical outcomes of patients with COVID-19 depending on receiving antihypertensive, lipid-lowering and antihypertensive therapy

Background. The main factors that increase the risk of cardiovascular accidents and mortality among patients with COVID-19 include hyperglycemia, arterial hypertension and dyslipidemia. Therefore, all patients with COVID-19 and metabolic syndrome should receive antihypertensive (AHT), hypolipidemic...

Full description

Saved in:
Bibliographic Details
Main Authors: Tatiana Yu. Demidova, Kristina G. Lobanova, Sergey N. Perekhodov, Michail B. Antsiferov, Olga S. Oynotkinova
Format: article
Language:RU
Published: "Consilium Medicum" Publishing house 2021
Subjects:
type 2 diabetes mellitus
hypertension
antihypertensive drugs
hypoglycemic drugs
covid-19
favipiravirum
Medicine
R
Online Access:https://doaj.org/article/a324d85d2b694f45bd8dce55506f770a
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/a324d85d2b694f45bd8dce55506f770a

Similar Items